Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PTGX
Stock Latest News
The Fly
Protagonist Therapeutics price target raised to $108 from $88 at Barclays
7d ago
PTGX
Premium
Ratings
Promising Clinical Data and Strategic Collaborations Drive Buy Rating for Protagonist Therapeutics
16d ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $115 from $98 at Citi
16d ago
PTGX
Premium
The Fly
Protagonist, Takeda present longer-term data at ASH 2025 on rusfertide
17d ago
TAK
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $65 from $47 at Goldman Sachs
1M ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $98 from $96 at Citi
1M ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $81 from $68 at JPMorgan
2M ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $88 from $72 at Barclays
2M ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $102 from $69 at Citizens JMP
2M ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $91 from $74 at Clear Street
2M ago
PTGX
Premium
Company Announcements
Protagonist Therapeutics Advances Pipeline Amid Financial Loss
2M ago
PTGX
Premium
Ratings
Promising Developments and Strategic Progress at Protagonist Therapeutics Drive Buy Rating
2M ago
PTGX
Premium
The Fly
Protagonist Therapeutics reports Q3 EPS (62c), consensus (64c)
2M ago
PTGX
Premium
Pre-Earnings
PTGX Earnings this Week: How Will it Perform?
2M ago
PTGX
Premium
The Fly
Protagonist Therapeutics price target raised to $88 from $76 at Truist
2M ago
PTGX
Premium
Ratings
Protagonist Therapeutics: Promising Prospects and Increased Price Target Amidst Positive Study Data and Strategic Partnerships
2M ago
PTGX
Premium
Ratings
Protagonist Therapeutics: Promising Drug Development and Strong Clinical Progress Justify Buy Rating
2M ago
PTGX
Premium
Ratings
Promising Potential of Protagonist Therapeutics’ Icotrokinra Drives Buy Rating Amid Strategic Interest from Johnson & Johnson
2M ago
PTGX
Premium
The Fly
Clear Street sees ‘unmatched commercial promise’ for Protagonist’s icotrokinra
2M ago
JNJ
PTGX
Premium
The Fly
Protagonist Therapeutics announces icotrokinra data in UC, plaque PsO
2M ago
PTGX
Premium
Market News
3 Stocks with a Flawless 10 Smart Score and Strong Buy Consensus
2M ago
IRON
PRAX
Premium
The Fly
Protagonist Therapeutics price target raised to $96 from $72 at Citi
2M ago
PTGX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
